Mary Ann Liebert, Inc., publishers

New lessons are being learned about risk assessment and predicting the extent of thyroid cancer occurrence following radiation exposure due to a nuclear power plant accident such as the one in March 2011 in Fukushima Prefecture of Japan.

The role and risks of bots, such as automated Twitter accounts, in influencing public opinion and political elections continues to provoke intense international debate and controversy.

Researchers now have a better understanding of the role that thyroid hormones, the tissues that produce them, and the biochemical pathways on which they act have in driving seasonal reproduction in some mammals, and how this new information may help...

A new study evaluating a form of Chinese massage, tuina, in patients with chronic neck pain found it to be effective, safe, and cost-effective compared to no treatment.

A special issue of LGBT Healthincludes the latest research, clinical practice innovations, and policy aimed at addressing disparities and enhancing healthcare for older LGBT populations.

Mary Ann Liebert, Inc., publishers announces the launch ofAutism in Adulthood, a new peer-reviewed journal dedicated to biological, neurological, psychological, cognitive, emotional, and behavioral research and scholarship on the most pressing issues...

A 10-year study of more than 1,200 patients with low-risk papillary microcarcinoma (PMC) of the thyroid led researchers to conclude that close and continuous monitoring is an acceptable first-line approach to patient management instead of immediate...

A new addition to a series of articles that focus on important topics related to the development of oligonucleotide therapeutics presents an in-depth look at the identification, characterization, and reporting of product-related impurities.

A nationwide study of school principals has shown that while the majority had assisted a victim of teen dating violence (TDV) recently, most of them had never received formal training in this area and their school did not have a specific protocol for...

As a gene therapy cure for hemophilia A moves closer to reality, a new study sheds light on a challenging complication in which a host autoimmune response inhibits the production of normal clotting factor VIII from the transferred FVIII gene.